BioWorld

Dec. 6, 2007

View Archived Issues

Adolor Inks $265M Deal With Pfizer For Opioid

Adolor Corp.'s beleaguered shares got a 20 percent boost on Wednesday after the company announced a $265 million deal with Pfizer Inc. for the delta opioid agonists ADL5859 and ADL5747. (BioWorld Today) Read More

Amarin Obtains MRNA Platform, Phase II Drug Via Acquisition

Read More

Bone Marrow Contributor To Tumor Vessel Growth Found

Read More

FDA Panel Votes Against Avastin Use For Breast Cancer Patients

Read More

United Kills Cancer Program Following Pivotal Trial Failures

Read More

Other News To Note

Read More

Clinic Roundup

Read More